VNRX Stock Summary and Trading Ideas (Volitionrx | AMEX:VNRX)

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Volitionrx trades on the AMEX stock market under the symbol VNRX.

As of March 4, 2025, VNRX stock price was flat at $0.62 with 100,784 million shares trading.

VNRX has a beta of 1.36, meaning it tends to be more sensitive to market movements. VNRX has a correlation of 0.03 to the broad based SPY ETF.

VNRX has a market cap of $59.50 million. This is considered a Micro Cap stock.

Last quarter Volitionrx reported $474,522 in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-177,478 and met earnings estimates .

In the last 3 years, VNRX traded as high as $3.30 and as low as $.43.

The top ETF exchange traded funds that VNRX belongs to (by Net Assets): VXF.

VNRX has underperformed the market in the last year with a return of -40.4%, while SPY returned +13.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in VNRX shares. However, VNRX has outperformed the market in the last 3 month and 2 week periods, returning +4.8% and -1.6%, while SPY returned -4.2% and -5.4%, respectively. This indicates VNRX has been having a stronger performance recently.

VNRX support price is $.58 and resistance is $.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VNRX shares will trade within this expected range on the day.